Kinetics of TCR use in response to repeated epitope-specific immunization

J Immunol. 2001 May 1;166(9):5817-25. doi: 10.4049/jimmunol.166.9.5817.

Abstract

Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies.

MeSH terms

  • Cancer Vaccines / administration & dosage*
  • Cancer Vaccines / immunology*
  • Clone Cells
  • Dose-Response Relationship, Immunologic
  • Down-Regulation / immunology
  • Epitopes, T-Lymphocyte / immunology*
  • Epitopes, T-Lymphocyte / metabolism
  • HLA Antigens / analysis
  • Humans
  • Immunization Schedule
  • Kinetics
  • Ligands
  • Lymphocyte Activation
  • Lymphocyte Count
  • Melanoma / immunology
  • Membrane Glycoproteins / administration & dosage
  • Membrane Glycoproteins / immunology
  • Neoplasm Proteins / administration & dosage
  • Neoplasm Proteins / immunology
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / immunology
  • Peptides
  • Protein Binding / immunology
  • Receptors, Antigen, T-Cell / metabolism*
  • Stem Cells / immunology
  • Stem Cells / metabolism
  • Stem Cells / pathology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / pathology
  • Tumor Cells, Cultured
  • gp100 Melanoma Antigen

Substances

  • Cancer Vaccines
  • Epitopes, T-Lymphocyte
  • HLA Antigens
  • Ligands
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • PMEL protein, human
  • Peptide Fragments
  • Peptides
  • Receptors, Antigen, T-Cell
  • g209-2M melanoma peptide
  • gp100 Melanoma Antigen